Displaying items by tag: division of laboratory medicine

Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.
Tagged under
This discovery may help treat patients with refractory thrombotic thrombocytopenic microangiopathy.
Platelet blood cells can carry an enzyme needed to prevent clots, while hiding it from autoantibody neutralization.
The event brings together physicians and researchers working to improve the available treatments, outcomes and recovery times for the disease.
UAB researchers will enroll patients for prospective studies on pathogenesis of a potentially fatal blood clot disorder with a $2.5 million NIH grant.
Similar to the ancient Greek legend of the Trojan horse, platelets in a transgenic mouse deliver a life-saving enzyme.